Literature DB >> 19871577

STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY.

W B Wood1, M R Smith, B Watson.   

Abstract

1. Evidence has been presented in previous publications that the phagocytosis of pneumococci in the pneumonic lung during chemotherapy is due neither to specific opsonins nor to capsular injury (1, 2). The present studies have shown that the phagocytosis taking place in the lung is independent of any sort of intermediary factor and results from a direct action of the phagocytic cells upon the pneumococci. 2. Phagocytosis in the absence of antibody has been demonstrated not only in the lungs of living rats but in formalin-fixed lungs, on the surfaces of a variety of tissues (both freshly removed from the animal and previously "killed" with heat), and on the surfaces of such inert materials as moistened filter paper, cloth, and fiber glass. On the other hand, smooth materials such as glass, cellophane, albumin, and paraffin have failed to support the phagocytic reaction. This latter observation indicates that the physical character of the surface to which the leucocytes have access constitutes a determining factor in the non-antibody mechanism of phagocytosis. 3. Further experiments have defined the relationship of "surface phagocytosis" to that induced by specific opsonins. The non-antibody mechanism was found to operate only upon surfaces of suitable physical properties, whereas opsonins enabled phagocytes floating freely in a fluid medium to engulf the fully encapsulated organisms. 4. Direct visualization of the surface phenomenon in the lung revealed that leucocytes phagocyte the virulent organisms in the absence of antibody only after having trapped them against the alveolar walls. Once the encapsulated pneumococci have been ingested, they can be seen to undergo digestion within a few hours. The discovery of the phenomenon of surface phagocytosis affords clarification of previously unanswered problems concerning the mechanism of recovery in pneumococcal pneumonia.

Entities:  

Keywords:  CONVALESCENCE; PHAGOCYTES AND PHAGOCYTOSIS; PNEUMOCOCCI/infections; PNEUMONIA/etiology and pathogenesis

Mesh:

Year:  1946        PMID: 19871577      PMCID: PMC2135630          DOI: 10.1084/jem.84.4.387

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  THE USE OF PENICILLIN IN THE LOCAL TREATMENT OF PNEUMOCOCCAL EMPYEMA.

Authors:  W S Tillett; J E McCormack; M J Cambier
Journal:  J Clin Invest       Date:  1945-07       Impact factor: 14.808

2.  THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA II. ACQUIRED IMMUNE SUBSTANCES.

Authors:  O H Robertson; J B Graeser; L T Coggeshall; M A Harrison
Journal:  J Clin Invest       Date:  1934-07       Impact factor: 14.808

3.  IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  M Finland; W C Spring; F C Lowell
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

4.  STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI.

Authors:  W C Spring; F C Lowell; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

5.  Surface Phagocytosis--Its Relation to the Mechanism of Recovery in Pneumococcal Pneumonia.

Authors:  W B Wood; M R Smith; B Watson
Journal:  Science       Date:  1946-07-12       Impact factor: 47.728

6.  CERTAIN ASPECTS OF MOUSE PROTECTION TESTS FOR ANTIBODY IN PNEUMOCOCCUS PNEUMONIA.

Authors:  F T Lord; E L Persons
Journal:  J Exp Med       Date:  1931-01-31       Impact factor: 14.307

7.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

8.  AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS.

Authors:  H K Ward; J F Enders
Journal:  J Exp Med       Date:  1933-03-31       Impact factor: 14.307

9.  THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : II. THE COURSE OF THE INFECTIOUS PROCESS.

Authors:  K Goodner; D K Miller
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

10.  CHANGES IN HUMORAL IMMUNITY OCCURRING DURING THE EARLY STAGES OF EXPERIMENTAL PNEUMOCOCCUS INFECTION.

Authors:  E E Terrell
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

View more
  35 in total

1.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLANDER'S BACILLUS : II. THE EFFECT OF SULFONAMIDE CHEMOTHERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL FRIEDLANDER'S BACILLUS PNEUMONIA.

Authors:  L Sale; M R Smith; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

2.  The influence of synovial fibroblasts on the phagocytosis of Staphylococcus by polymorphonuclear cells.

Authors:  D van Riessen; M R Daha; T J Smeets; F C Breedveld
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.

Authors:  D L Gordon; J L Rice; V M Avery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 4.  Role of the polymorphonuclear leukocyte: interaction with nosocomial pathogens.

Authors:  G B Toews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

Review 5.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

6.  The effect of intraalveolar fluid on lung bacterial clearance.

Authors:  G D Harris; D E Woods; R Fine; W G Johanson
Journal:  Lung       Date:  1980       Impact factor: 2.584

7.  Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.

Authors:  Christopher B Hergott; Aoife M Roche; Nikhil A Naidu; Clementina Mesaros; Ian A Blair; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2015-08-31       Impact factor: 14.808

8.  An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery.

Authors:  M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307

9.  The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III.

Authors:  W B WOOD; M R SMITH
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

10.  On the nature of bacteremia in experimental pneumococcal pneumonia in the dog. II. Disappearance of pneumococci from the circulation in relation to the bactericidal action of the blood in vitro.

Authors:  L A GREGG; O H ROBERTSON
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.